The role of radiation therapy in the management of cutaneous melanoma

Surgical Oncology Clinics of North America

Volumn 20, Issue 1, 2011, Pages 115-131

  Rao, Nikhil G ^a   Yu, Hsiang Hsuan M ^a   Trotti, Andrea ^a   Sondak, Vernon K ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Chemotherapy; Melanoma; Metastases; Radiation; Stereotactic

Indexed keywords

ALPHA2B INTERFERON; DACARBAZINE; TEMOZOLOMIDE;

BONE METASTASIS; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DESMOPLASTIC MELANOMA; ELECTRON THERAPY; HUMAN; HYPERTHERMIC THERAPY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALIGNANT LENTIGO; MELANOMA; METASTASIS POTENTIAL; OVERALL SURVIVAL; POSTOPERATIVE CARE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; SKIN CANCER; SPINE METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; STEREOTAXIC SURGERY; SURVIVAL TIME; TREATMENT INDICATION; WHOLE BODY RADIATION;

BRAIN NEOPLASMS; HUMANS; MELANOMA; NEOPLASM METASTASIS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 78649462524     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.09.005     Document Type: Review

References (60)

1. Hellriegel W. Radiation therapy of primary and metastatic melanoma. Ann N Y Acad Sci 1963, 100:131-141.
2. Schmidt-Ullrich R.K., Johnson C.R. Role of radiotherapy and hyperthermia in the management of malignant melanoma. Semin Surg Oncol 1996, 12:407-415.
3. Ballo M.T., Ang K.K. Radiotherapy for cutaneous malignant melanoma: rationale and indications. Oncology (Williston Park) 2004, 18:99-107. [discussion: 107-10, 113-4].
4. Arora A., Lowe L., Su L., et al. Wide excision without radiation for desmoplastic melanoma. Cancer 2005, 104:1462-1467.
5. Quinn M.J., Crotty K.A., Thompson J.F., et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998, 83:1128-1135.
6. Vongtama R., Safa A., Gallardo D., et al. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck 2003, 25:423-428.
7. Chen J.Y., Hruby G., Scolyer R.A., et al. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer 2008, 113:2770-2778.
8. Agrawal S., Kane J.M., Guadagnolo B.A., et al. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer 2009, 115:5836-5844.
9. Ballo M.T., Ross M.I., Cormier J.N., et al. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 2006, 64:106-113.
10. Guadagnolo B.A., Zagars G.K. Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol 2009, 10:409-416.
11. Guadagnolo B.A., Myers J.N., Zagars G.K. Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: a critical assessment. Head Neck 2010, 32:708-713.
12. Creagan E.T., Cupps R.E., Ivins J.C., et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: a randomized, prospective study. Cancer 1978, 42:2206-2210.
13. Burmeister B., Smithers B.M., Thompson J.F., et al. Adjuvant radiotherapy improves regional (lymph node field) control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (TROG 02.01/ANZMTG 01.02). Int J Radiat Oncol Biol Phys 2009, 75(Suppl 3):S2.
14. Burmeister B.H., Smithers B.M., Davis S., et al. Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity. ANZ J Surg 2002, 72:344-348.
15. Ballo M.T., Garden A.S., Myers J.N., et al. Melanoma metastatic to cervical lymph nodes: can radiotherapy replace formal dissection after local excision of nodal disease?. Head Neck 2005, 27:718-721.
16. Bonnen M.D., Ballo M.T., Myers J.N., et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 2004, 100:383-389.
17. Mocellin S., Pasquali S., Rossi C.R., et al. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst 2010, 102:493-501.
18. Hazard L.J., Sause W.T., Noyes R.D. Combined adjuvant radiation and interferon-alpha 2B therapy in high-risk melanoma patients: the potential for increased radiation toxicity. Int J Radiat Oncol Biol Phys 2002, 52:796-800.
19. Conill C., Jorcano S., Domingo-Domenech J., et al. Toxicity of combined treatment of adjuvant irradiation and interferon alpha2b in high-risk melanoma patients. Melanoma Res 2007, 17(5):304-309.
20. Gyorki D.E., Ainslie J., Joon M.L., et al. Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma - a retrospective single centre study. Melanoma Res 2004, 14:223-230.
21. Nguyen N.P., Sallah S., Childress C., et al. Interferon-alpha combined with radiotherapy in the treatment of unresectable melanoma. Cancer Invest 2001, 19:261-265.
22. Finkelstein S., Trotti A., Reintgen D., et al. The Florida Melanoma Trial I: a prospective multi-center phase I/II trial of post operative hypofractionated adjuvant radiotherapy with concurrent interferon-alfa-2b in the treatment of advanced stage III melanoma. Int J Radiat Oncol Biol Phys 2008, 72(Suppl 1):S108.
23. Gogas H.J., Kirkwood J.M., Sondak V.K. Chemotherapy for metastatic melanoma: time for a change?. Cancer 2007, 109:455-464.
24. Dewit L., Bartelink H., Rumke P. Concurrent cis-diamminedichloroplatinum(II) and radiation treatment for melanoma metastases: a pilot study. Radiother Oncol 1985, 3:303-309.
25. Klausner J.M., Gutman M., Rozin R.R., et al. Conventional fractionation radiotherapy combined with 5-fluorouracil for metastatic malignant melanoma. Am J Clin Oncol 1987, 10:448-450.
26. Gill P.G., Abbott R.L., Ahmad A., et al. Effective palliation of melanoma with procarbazine and radiotherapy given by a low-dose fractionation schedule. Med J Aust 1986, 144:126-128.
27. Quirt I., Verma S., Petrella T., et al. Temozolomide for the treatment of metastatic melanoma: a systematic review. Oncologist 2007, 12:1114-1123.
28. Overgaard J., Gonzalez D., Hulshof M.C., et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995, 345:540-543.
29. Jones E.L., Oleson J.R., Prosnitz L.R., et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005, 23:3079-3085.
30. Stevens G., Thompson J.F., Firth I., et al. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer 2000, 88:88-94.
31. Chang D.T., Amdur R.J., Morris C.G., et al. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys 2006, 66:1051-1055.
32. Sause W.T., Cooper J.S., Rush S., et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991, 20:429-432.
33. Patchell R.A., Tibbs P.A., Regine W.F., et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366:643-648.
34. Gerszten P.C., Burton S.A., Quinn A.E., et al. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg 2005, 83:213-221.
35. Rusthoven K.E., Kavanagh B.D., Burri S.H., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27:1579-1584.
36. Corry J., Smith J.G., Bishop M., et al. Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 1999, 44(5):1065-1069.
37. Seegenschmiedt M.H., Keilholz L., Altendorf-Hofmann A., et al. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys 1999, 44:607-618.
38. Olivier K.R., Schild S.E., Morris C.G., et al. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer 2007, 110:1791-1795.
39. Amer M.H., Al-Sarraf M., Baker L.H., et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42:660-668.
40. Sampson J.H., Carter J.H., Friedman A.H., et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11-20.
41. Sperduto P.W., Chao S.T., Sneed P.K., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661.
42. Gelber R.D., Larson M., Borgelt B.B., et al. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981, 48:1749-1753.
43. Asai A., Matsutani M., Kohno T., et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 1989, 63:1962-1974.
44. Margolin K., Atkins B., Thompson A., et al. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol 2002, 128:214-218.
45. Atkins M.B., Sosman J.A., Agarwala S., et al. Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study. Cancer 2008, 113:2139-2145.
46. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
47. Wronski M., Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000, 93:9-18.
48. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485-1489.
49. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
50. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491.
51. Chang E.L., Wefel J.S., Hess K.R., et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-1044.
52. Liew D.N., Kano H., Kondziolka D., et al. Outcome predictors of gamma knife surgery for melanoma brain metastases. J Neurosurg 2010, [Epub ahead of print].
53. Karlovits B.J., Quigley M.R., Karlovits S.M., et al. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 2009, 27:E7.
54. Soltys S.G., Adler J.R., Lipani J.D., et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008, 70:187-193.
55. Gerszten P.C., Burton S.A., Ozhasoglu C., et al. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007, 32:193-199.
56. Milano M.T., Katz A.W., Schell M.C., et al. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:1516-1522.
57. Noordijk E.M., Vecht C.J., Haaxma-Reiche H., et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994, 29:711-717.
58. Mintz A.H., Kestle J., Rathbone M.P., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476.
59. Kondziolka D., Patel A., Lunsford L.D., et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.
60. Muacevic A., Wowra B., Siefert A., et al. Microsurgery plus whole brain irradiation versus gamma knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008, 87:299-307.